COMMUNITY HEALTH SYSTEMS INC (CYH) Stock Fundamental Analysis
NYSE:CYH - New York Stock Exchange, Inc. - US2036681086 - Common Stock - Currency: USD
CYH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CYH while its profitability can be described as average. CYH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
CYH had negative earnings in the past year.
CYH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CYH reported negative net income in multiple years.
Of the past 5 years CYH 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.41%, CYH is in line with its industry, outperforming 44.66% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.13%, CYH is in the better half of the industry, outperforming 64.08% of the companies in the same industry.
CYH had an Average Return On Invested Capital over the past 3 years of 5.27%. This is below the industry average of 9.72%.
The last Return On Invested Capital (6.13%) for CYH is above the 3 year average (5.27%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.41% | ||
| ROE | N/A | ||
| ROIC | 6.13% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
1.3 Margins
The Operating Margin of CYH (6.96%) is better than 70.87% of its industry peers.
CYH's Operating Margin has been stable in the last couple of years.
The Gross Margin of CYH (84.71%) is better than 97.09% of its industry peers.
CYH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.96% | ||
| PM (TTM) | N/A | ||
| GM | 84.71% |
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CYH is creating some value.
CYH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CYH has more shares outstanding
The debt/assets ratio for CYH is higher compared to a year ago.
2.2 Solvency
CYH has an Altman-Z score of 0.88. This is a bad value and indicates that CYH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.88, CYH is doing worse than 71.84% of the companies in the same industry.
CYH has a debt to FCF ratio of 79.88. This is a negative value and a sign of low solvency as CYH would need 79.88 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 79.88, CYH is doing worse than 62.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 79.88 | ||
| Altman-Z | 0.88 |
ROIC/WACC1.13
WACC5.44%
2.3 Liquidity
CYH has a Current Ratio of 1.59. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
CYH has a Current ratio (1.59) which is comparable to the rest of the industry.
A Quick Ratio of 1.45 indicates that CYH should not have too much problems paying its short term obligations.
CYH's Quick ratio of 1.45 is in line compared to the rest of the industry. CYH outperforms 54.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
CYH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.81%, which is quite impressive.
Looking at the last year, CYH shows a small growth in Revenue. The Revenue has grown by 0.79% in the last year.
Measured over the past years, CYH shows a decrease in Revenue. The Revenue has been decreasing by -0.89% on average per year.
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.59%
Revenue 1Y (TTM)0.79%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%-0.22%
3.2 Future
Based on estimates for the next years, CYH will show a very strong growth in Earnings Per Share. The EPS will grow by 26.56% on average per year.
Based on estimates for the next years, CYH will show a small growth in Revenue. The Revenue will grow by 1.94% on average per year.
EPS Next Y72.94%
EPS Next 2Y38.97%
EPS Next 3Y26.56%
EPS Next 5YN/A
Revenue Next Year-1.16%
Revenue Next 2Y0.98%
Revenue Next 3Y1.94%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CYH. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CYH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
75.73% of the companies in the same industry are more expensive than CYH, based on the Enterprise Value to EBITDA ratio.
99.03% of the companies in the same industry are more expensive than CYH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.66 | ||
| EV/EBITDA | 8.08 |
4.3 Compensation for Growth
CYH's earnings are expected to grow with 26.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.97%
EPS Next 3Y26.56%
5. Dividend
5.1 Amount
No dividends for CYH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.58
-0.19 (-6.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.69%
Inst Owner Change-1.24%
Ins Owners8.61%
Ins Owner Change4.74%
Market Cap362.00M
Analysts70
Price Target4.37 (69.38%)
Short Float %10.6%
Short Ratio5.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.59%
Min EPS beat(2)52.57%
Max EPS beat(2)62.61%
EPS beat(4)2
Avg EPS beat(4)-138.61%
Min EPS beat(4)-607.99%
Max EPS beat(4)62.61%
EPS beat(8)3
Avg EPS beat(8)-184.07%
EPS beat(12)5
Avg EPS beat(12)-182.87%
EPS beat(16)8
Avg EPS beat(16)-462.39%
Revenue beat(2)2
Avg Revenue beat(2)1.86%
Min Revenue beat(2)0.99%
Max Revenue beat(2)2.72%
Revenue beat(4)3
Avg Revenue beat(4)1.4%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)2.72%
Revenue beat(8)5
Avg Revenue beat(8)0.82%
Revenue beat(12)6
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.08%
PT rev (1m)2.24%
PT rev (3m)6.7%
EPS NQ rev (1m)1.87%
EPS NQ rev (3m)-16.62%
EPS NY rev (1m)-11.52%
EPS NY rev (3m)-22.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.43%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | 2.66 | ||
| P/OCF | 0.74 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.08 |
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.97
FCFY37.57%
OCF(TTM)3.5
OCFY135.64%
SpS90.14
BVpS-11.62
TBVpS-37.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.41% | ||
| ROE | N/A | ||
| ROCE | 7.76% | ||
| ROIC | 6.13% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 9.54% | ||
| OM | 6.96% | ||
| PM (TTM) | N/A | ||
| GM | 84.71% | ||
| FCFM | 1.08% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
ROICexc(3y)5.3%
ROICexc(5y)5.61%
ROICexgc(3y)7.93%
ROICexgc(5y)8.5%
ROCE(3y)6.68%
ROCE(5y)6.87%
ROICexcg growth 3Y-11.89%
ROICexcg growth 5Y0.9%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y0.93%
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
F-Score7
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 79.88 | ||
| Debt/EBITDA | 8.11 | ||
| Cap/Depr | 77.85% | ||
| Cap/Sales | 2.81% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 36.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 0.88 |
F-Score7
WACC5.44%
ROIC/WACC1.13
Cap/Depr(3y)81.42%
Cap/Depr(5y)81.99%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.59%
EPS Next Y72.94%
EPS Next 2Y38.97%
EPS Next 3Y26.56%
EPS Next 5YN/A
Revenue 1Y (TTM)0.79%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%-0.22%
Revenue Next Year-1.16%
Revenue Next 2Y0.98%
Revenue Next 3Y1.94%
Revenue Next 5YN/A
EBIT growth 1Y-6.78%
EBIT growth 3Y-12.97%
EBIT growth 5Y-1.39%
EBIT Next Year55.28%
EBIT Next 3Y18.15%
EBIT Next 5YN/A
FCF growth 1Y163.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.17%
OCF growth 3YN/A
OCF growth 5Y4.51%